Analysis of Risk Factors of Nosocomial Infection in Patients With Cirrhosis and Nursing Countermeasures of Traditional Chinese Medicine

目的探究肝硬化患者产生医院感染的危险因素,并采用中医预防及护理对策,为临床防控医院感染提供参考。方法收集2014年10月1日—2016年10月31日住院治疗的176例肝硬化患者资料,回顾性分析医院感染产生的危险因素,并总结中医预防及护理对策。结果176例肝硬化患者中有5例发生医院感染,其感染率是2.84%,感染部位主要有三种,即肺部感染、胃肠道及腹腔感染,其中,居于感染部位首位的是肺部感染3例（60%）,其次为肠道感染1例（20%）和腹腔感染1例（20%）。5例感染病例均采样送细菌培养,检出4株病原菌,分别为2株的肺炎克雷伯菌（50%）,1株的大肠埃希菌（25%）,1株金黄色葡萄球菌（25%）。年龄≥55岁,住院时间≥30 d、侵入性操作、预防用药、肝功能评级高、合并肝炎是肝硬化患者发生医院感染的危险因素。结论针对肝硬化患者发生医院感染的危险因素,采取相应的中医预防及护理,增强身体免疫能力,可提高肝硬化患者生活质量,促进疾病恢复。Objective To explore the risk factors of nosocomial infection in patients with cirrhosis, and to take preventive and nursing measures toprovide reference for the clinical prevention and control of nosocomial infection. Methods The data of 176 hospitalized patients with cirrhosis from October 1, 2014 to October 31, 2016 were collected. The risk factors of nosocomial infection were analyzed retrospectively, and the countermeasures of prevention and nursing were also summarized. Results There were 5 cases of nosocomial infection occurred in 176 cases of cirrhosis patients, the infection rate was 2.84%, the main infection sites had three kinds, namely, pulmonary infection, gastrointestinal and abdominal infection. Among them, the first place of infection was pulmonary infection（3 cases,60%）, followed by intestinal infection（1 case,20%） and abdominal cavity infection（1 case,20%）. 5 cases of infection were sampled for bacterial culture. 4 strains of pathogenic bacteria were detected, including2 strains of Klebsiella pneumoniae（50%）, 1 strain of Escherichia coli（25%）, and 1 strain of Staphylococcus aureus（25%）. 55 years of age or older, more than 30 days hospitalization, invasive operation, prophylactic antibiotics use, the liver function rating was high, complicated hepatitis,were the risk factors for nosocomial infection in patients with cirrhosis.Conclusion According to the risk factors of nosocomial infection in patients with cirrhosis, we should take corresponding prevention and care of the traditional Chinese medicine to enhance the ability of body immunity,improve the quality of life of patients with cirrhosis, and promote the recovery of disease

Major causes of death in children less than 5 years of age in Fujian,China,2007-2010

目的分析福建省2007-2010年5岁以下儿童主要死亡原因情况及特征,为制定干预措施提供科学依据。方法 分析死因登记信息网络报告系统上报的福建省2007-2010年5岁以下儿童死因及特征。结果 2007-2010年福建省共报告6 166例5岁以下儿童死亡病例,年平均死亡率为6.28/万,各年龄组即0--岁、1--岁、2--岁、3--岁、4--5岁的死亡率分别为44.89/万、5.48/万、3.28/万、2.38/万、1.76/万。1岁以下占78.74%,1岁以下死亡儿童出生28d内死亡的占64.33%;病例的死亡时间均匀的分布在12个月份,没有明显的高峰时间;死亡地点主要在住院死亡(63.87%),最高诊断依据主要是单纯临床诊断(53.50%),最高级别诊断单位主要是地市级医院(42.96%);前5位的死因分别为围产期疾病、先天异常、伤害、流行性感冒和肺炎、传染病和寄生虫病,合计构成比为69.45%。结论 福建省2007-2010年5岁以下儿童死亡中,以婴儿死亡居多,婴儿死亡中又以新生儿死亡居多。围产期疾病、先天异常、伤害是5岁以下儿童死亡的三大死因。5岁以下儿童死因中先天性异常的比例在逐年上升,循环系统疾病比例在逐年下降。Objective To analyze major causes of death in children under 5 years of age in Fujian,China,and to provide scientific evidence for the protection of infants and young children.Methods The data of 2007-2010 death cases were collected from China Disease Report Information System for children under 5 years of age in Fujian.Microsoft Excel and SPSS 15.0 packages were respectively used to establish the database and to analyze the data.Results A total of 6 166 death cases were reported from 2007 to 2010 for children less than 5 years of age.Death rate was 62.8 /lakh on average.The death rates of children under 1,2,3,4 and 5 years of age were 448.9,54.8,32.8,23.8 and 17.6/lakh,respectively.The number of infant death accounted for 78.74% of cases.64.33% of infant death occurred in newborn babies.There was no seasonal difference for the cases of death.Most cases of death(63.87%) occurred in hospital.The top five causes of death were periparturient diseases,congenital malformations,injuries,influenza and following pneumonia,infectious and parasitic diseases,respectively,together of which accounted for 69.45% of death cases.Conclusion Newborn babies and infants were high risk groups for the death of children under 5 years of age in Fujian.The increasing trend of congenital malformation related death suggests the importance of prenatal screening testing